Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 161579, 7 pages
http://dx.doi.org/10.1155/2015/161579
Research Article

T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea

1Department of Pneumonology and Allergology, Medical University of Warsaw, Ulica Banacha 1a, 02 097 Warsaw, Poland
2Laboratory of Flow Cytometry, Medical Centre of Postgraduate Education, Ulica Marymoncka 99, 01 813 Warsaw, Poland

Received 12 January 2015; Revised 12 May 2015; Accepted 12 May 2015

Academic Editor: Tânia Silvia Fröde

Copyright © 2015 Joanna Domagała-Kulawik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Pływaczewski, M. Bednarek, L. Jonczak, and J. Zieliński, “Sleep-disordered breathing in a middle-aged and older Polish urban population,” Journal of Sleep Research, vol. 17, no. 1, pp. 73–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Arnaud, M. Dematteis, J.-L. Pepin, J.-P. Baguet, and P. Lévy, “Obstructive sleep apnea, immuno-inflammation, and atherosclerosis,” Seminars in Immunopathology, vol. 31, no. 1, pp. 113–125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. W. T. McNicholas and M. R. Bonsignore, Eds., Sleep Apnea, Europen Respiratory Society Monograph, ERS, 2010.
  4. E. S. Arnardottir, M. Mackiewicz, T. Gislason, K. L. Teff, and A. I. Pack, “Molecular signatures of obstructive sleep apnea in adults: a review and perspective,” Sleep, vol. 32, no. 4, pp. 447–470, 2009. View at Google Scholar · View at Scopus
  5. L. Lavie, “Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea,” Frontiers in Bioscience, vol. 4, no. 4, pp. 1391–1403, 2012. View at Google Scholar · View at Scopus
  6. P. Lavie and L. Lavie, “Cardiovascular morbidity and mortality in obstructive sleep apnea,” Current Pharmaceutical Design, vol. 14, no. 32, pp. 3466–3473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Aihara, T. Oga, Y. Chihara et al., “Analysis of systemic and airway inflammation in obstructive sleep apnea,” Sleep and Breathing, vol. 17, no. 2, pp. 597–604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Testelmans, R. Tamisier, G. Barone-rochette et al., “Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events,” Cytokine, vol. 62, no. 2, pp. 210–216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Al Mutairi, O. A. Mojiminiyi, A. Al Alawi, T. Al Rammah, and N. Abdella, “Study of leptin and adiponectin as disease markers in subjects with obstructive sleep apnea,” Disease Markers, vol. 2014, Article ID 706314, 8 pages, 2014. View at Publisher · View at Google Scholar
  10. B. Gustafson, “Adipose tissue, inflammation and atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 4, pp. 332–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Dyugovskaya, P. Lavie, and L. Lavie, “Phenotypic and functional characterization of blood γδ T cells in sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 2, pp. 242–249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Dyugovskaya, P. Lavie, M. Hirsh, and L. Lavie, “Activated CD8+ T-lymphocytes in obstructive sleep apnoea,” European Respiratory Journal, vol. 25, no. 5, pp. 820–828, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Lavie, L. Dyugovskaya, and A. Polyakov, “Biology of peripheral blood cells in obstructive sleep apnea—the tip of the iceberg,” Archives of Physiology and Biochemistry, vol. 114, no. 4, pp. 244–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. “Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force,” Sleep, vol. 22, no. 5, pp. 667–689, 1999.
  15. R. Plywaczewski, A. Brzecka, P. Bielicki et al., “Sleep related breathing disorders in adults—recommendations of Polish Society of Lung Diseases,” Pneumonologia i Alergologia Polska, vol. 81, no. 3, pp. 221–258, 2013. View at Google Scholar
  16. M. W. Johns, “A new method for measuring daytime sleepiness: the Epworth sleepiness scale,” Sleep, vol. 14, no. 6, pp. 540–545, 1991. View at Google Scholar · View at Scopus
  17. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Domagała-Kulawik, G. Hoser, M. Kawalec, A. Doboszyńska, J. Kawiak, and W. Droszcz, “Lymphocyte phenotyping in systemic sclerosis: a flow cytometry analysis of lymphocytes in bronchoalveolar lavage fluid,” Analytical and Quantitative Cytology and Histology, vol. 19, no. 3, pp. 264–270, 1997. View at Google Scholar · View at Scopus
  19. J. Domagała-Kulawik, G. Hoser, M. Dabrowska, and R. Chazan, “Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD,” Respiratory Medicine, vol. 101, no. 6, pp. 1338–1343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Hoser, J. Domagała-Kulawik, P. Droszcz, W. Droszcz, and J. Kawiak, “Lymphocyte subsets differences in smokers and nonsmokers with primary lung cancer: a flow cytometry analysis of bronchoalveolar lavage fluid cells,” Medical Science Monitor, vol. 9, no. 8, pp. BR310–BR315, 2003. View at Google Scholar · View at Scopus
  21. H. K. Eltzschig and P. Carmeliet, “Hypoxia and inflammation,” The New England Journal of Medicine, vol. 364, no. 7, pp. 656–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-L. Tan, D. Gozal, Y. Wang et al., “Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea,” Sleep, vol. 36, no. 6, pp. 913–922, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Campbell and J. Hasegawa, “Natural killer cell biology: an update and future directions,” Journal of Allergy and Clinical Immunology, vol. 132, no. 3, pp. 536–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Rijavec, S. Volarevic, K. Osolnik, M. Kosnik, and P. Korosec, “Natural killer T cells in pulmonary disorders,” Respiratory Medicine, vol. 105, supplement 1, pp. S20–S25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Tang, X. Li, M. Wang et al., “Increased numbers of NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease,” Clinical and Developmental Immunology, vol. 2013, Article ID 721782, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Pichavant, G. Remy, S. Bekaert et al., “Oxidative stress-mediated iNKT-cell activation is involved in COPD pathogenesis,” Mucosal Immunology, vol. 7, no. 3, pp. 568–578, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. G. S. Getz, P. A. Vanderlaan, and C. A. Reardon, “Natural killer T cells in lipoprotein metabolism and atherosclerosis,” Thrombosis and Haemostasis, vol. 106, no. 5, pp. 814–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Lynch, M. Nowak, B. Varghese et al., “Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production,” Immunity, vol. 37, no. 3, pp. 574–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Andoh, H. Ogura, M. Satoh et al., “Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice,” Immunobiology, vol. 218, no. 4, pp. 561–569, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. G. S. Getz, P. A. Vanderlaan, and C. A. Reardon, “Natural killer T cells in lipoprotein metabolism and atherosclerosis,” Thrombosis and Haemostasis, vol. 106, no. 5, pp. 814–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. W. Klinker and S. K. Lundy, “Multiple mechanisms of immune suppression by B lymphocytes,” Molecular Medicine, vol. 18, no. 1, pp. 123–137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Exley, L. Hand, D. O'Shea, and L. Lynch, “Interplay between the immune system and adipose tissue in obesity,” Journal of Endocrinology, vol. 223, no. 2, pp. R41–R48, 2014. View at Publisher · View at Google Scholar
  33. N. Rovina, A. Koutsoukou, and N. G. Koulouris, “Inflammation and immune response in COPD: where do we stand?” Mediators of Inflammation, vol. 2013, Article ID 413735, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. B. K. Pendersen and A. D. Toft, “Effects of exercise on lymphocytes and cytokines,” British Journal of Sports Medicine, vol. 34, no. 4, pp. 246–251, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. B. K. Pedersen and L. Hoffman-Goetz, “Exercise and the immune system: regulation, integration, and adaptation,” Physiological Reviews, vol. 80, no. 3, pp. 1055–1081, 2000. View at Google Scholar · View at Scopus
  36. T.-S. Tsao, E. Tomas, H. E. Murrey et al., “Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways,” The Journal of Biological Chemistry, vol. 278, no. 50, pp. 50810–50817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Wang, “Obesity, inflammation, and lung injury (OILI): the good,” Mediators of Inflammation, vol. 2014, Article ID 978463, 15 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kosacka, A. Korzeniewska, and R. Jankowska, “The evaluation of body composition, adiponectin, C-reactive protein and cholesterol levels in patients with obstructive sleep apnea syndrome,” Advances in Clinical and Experimental Medicine, vol. 22, no. 6, pp. 817–824, 2013. View at Google Scholar · View at Scopus